<DOC>
	<DOCNO>NCT01376635</DOCNO>
	<brief_summary>Background/Aims : To evaluate sympathovagal balance patient chronic kidney disease ( CKD ) conservative treatment . Methods : In cross-sectional study , patient CKD stag 3 , 4 5 yet dialysis ( CKD group ) age-matched healthy subject ( CON group ) underwent continuous heart rate record two twenty-minute period supine position ( pre-inclined ) , follow passive postural inclination 70° ( inclined period ) . Power spectral analysis heart rate variability use assess normalized low frequency ( LFnu ) , indicative sympathetic activity , normalize high frequency ( HFnu ) , indicative parasympathetic activity . The LFnu/HFnu ratio represent sympathovagal balance .</brief_summary>
	<brief_title>Depressed Cardiac Autonomic Modulation Patients With Chronic Kidney Disease Diagnosed Spectral Analysis</brief_title>
	<detailed_description>Patients We evaluate 32 individual ( 18 men 14 woman ) CKD stag 3 , 4 5 yet dialysis . The individual recruit Interdisciplinary Nucleus Studies , Research Treatment Nephrology , Federal University Juiz de Fora . All patient follow nephrologist least 6 month inclusion study . Patients severe cardiac disease , cancer , diabetes , collagen demyelinating disease , leave ventricular systolic dysfunction , history stroke exclude . The control group consist 14 subject normal renal function non-diabetic , normotensive free heart disease . The study approve Ethics Committee University Hospital Federal University Juiz de Fora , document number 073/2007 , subject sign informed consent include protocol . Study Design This cross-sectional study evaluate ANS function patient CKD conservative treatment compare result control group . Power spectral analysis HRV rest passive orthostatic stress perform group . Cardiovascular Evaluation The medical evaluation perform cardiologist consist interview clinical examination . Blood pressure measure 2 minute interval use conventional sphygmomanometer . A conventional 12-lead electrocardiogram ( ECG ) perform electrocardiograph ( model Apex 1000 , TEB , Brazil ) . To detect LVH , use Cornell criterion [ 9 ] . Ventricular geometry function analyze use two-dimensional Doppler echocardiogram generate use Philips EnVisor C Ultrasound System ( Philips Medical Systems-Ultrasound , MA , USA ) . Measurements indices leave ventricular function rest obtain two-dimensional M mode , use 3.5 MHz linear transducer place third fourth intercostal space . The diagnosis LVH base leave ventricular mass index ( LVMI ) , value consider normal 115 g/m2 men 95 g/m2 woman [ 10 ] . The data interpret accord criterion establish American Society Echocardiography [ 11 ] . Laboratory Evaluation The result follow test obtain patient ' chart : glomerular filtration rate ( eGFR ; estimate creatinine use Modification Diet Renal Disease equation ) [ 12 ] , urea , potassium , calcium , phosphorus , hemoglobin , uric acid , parathyroid hormone ( PTH ) , total cholesterol , HDL cholesterol , LDL cholesterol , triglyceride , glucose urinalysis . The diagnosis CKD base Kidney Disease Outcomes Quality Initiative National Kidney Foundation ( KDOQI/NKF ) [ 13 ] : eGFR &lt; 60 ml/min/1.73 m2 and/or least one marker renal parenchymal damage ( e.g. , proteinuria ) , present period ≥3 month . Analysis Heart Rate Variability The HRV measure rest supine position orthostatic stress . All subject instruct fast six hour smoke drink caffeine 12 hour prior test . All medication could potentially interfere cardiovascular response non-dihydropyridine calcium channel blocker , beta-blockers , central sympatholytic , tricyclic antidepressant well anti-arrhythmic drug withdraw least five drug half-lives study . The evaluation conduct morning calm environment low light tilt table seat belt platform footrest . The subject underwent continuous HR record use Holter system ( Cardio Light , Brazil ) two 20 minute period supine position ( pre-inclined ) , follow passive postural inclination 70° ( inclined period ) [ 14,15 ] . To evaluate spectral analysis HRV , fast Fourier transform use [ 16 ] , obtain mean Holter-specific software ( Cardio Smart 550 , Brazil ) , allow periodic signal , average 500 sequential R-R interval , divide various band frequency response : ultra-low frequency ( ULF : &lt; 0.0033 Hz ) , low frequency ( VLF : 0.0033 0.04 Hz ) , low frequency ( LF : 0.04 0.15 Hz ) , high frequency ( HF : 0.15 0.4 Hz ) . The LF HF component use marker sympathetic parasympathetic activity , respectively , LF/HF ratio use measure sympathovagal balance . To minimize effect change ULF VLF band , data normalize result express normalized unit ( nu ) . The normalization do divide power give component ( LF HF ) total power spectrum ; result , VLF component subtract , number multiply 100 . Thus , variable use HRV analysis LFnu , HFnu LFnu/HFnu ratio . The data interpret follow previously publish guideline [ 17 ] . The HRV analyze use high total power express msec² , obtain 10 minute supine position first 5 minute tilt table . Statistical Analysis The variable describe mean , standard deviation , percentage median . The descriptive statistic normality data test Kolmogorov Smirnov test . The laboratory data control CKD group baseline compare use independent sample T test , Chi-square test Mann Whitney test depend characteristic variable . Spectral analysis heart rate variability assess within group pre-inclined inclined period Kruskal Wallis ANOVA ( post Hoc test ) control group CKD group divide disease stage three , four five . The LFnu / HFnu ratio control CKD group compare Mann Whitney Test . To assess correlation CKD stag biochemical variable LFnu/HFnu ratio , Spearman 's linear correlation coefficient use . A p value less equal 0.05 consider statistically significant . All analysis perform use SPSS 13.0 Windows ( SPSS Inc. , Chicago , USA ) .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<criteria>We evaluate 32 individual ( 18 men 14 woman ) CKD stag 3 , 4 5 yet dialysis Patients severe cardiac disease , cancer , diabetes , collagen demyelinating disease , leave ventricular systolic dysfunction , history stroke exclude</criteria>
	<gender>All</gender>
	<minimum_age>44 Years</minimum_age>
	<maximum_age>69 Years</maximum_age>
	<verification_date>May 2008</verification_date>
	<keyword>Chronic Kidney Disease</keyword>
	<keyword>Autonomic Dysfunction</keyword>
</DOC>